Robert Luther Huffines
Known title: DirectorCIK: 0001728221
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
BDX Revello Stent Trial Success, Revenue Up 5.4%, Earnings Down 34%. The company announced that its Revello stent achieved strong results in the AGILITY trial for peripheral artery disease patients. Revenue rose 5.4% year‑over‑year, but net earnings fell 34.3%, reflecting higher costs or lower margins. The dividend yield sits at 1.59% and analysts see a target of $194, while the stock trades near the top of its 52‑week range.
Transaction History
| PODD | ▲ Buy | Grant | 178 | $23K | 9/30/2026 | View on chart |
| PODD | ▲ Buy | Grant | 144 | $23K | 6/30/2026 | View on chart |
| PODD | ▲ Buy | Grant | 1,660 | $0 | 5/20/2026 | View on chart |
| PODD | ▲ Buy | Grant | 111 | $23K | 3/31/2026 | View on chart |
| BDX | ▲ Buy | Grant | 1,098 | $0 | 1/27/2026 | View on chart |
| PODD | ▲ Buy | Grant | 51 | $14K | 12/31/2025 | View on chart |
| BDX | ▲ Buy | Grant | 180 | $0 | 12/1/2025 | View on chart |
| PODD | ▲ Buy | Grant | 477 | $0 | 10/31/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Insulet Sets Q3 2026 Earnings Date for Nov 4
Insulet has scheduled its third-quarter 2026 financial results for release on November 4, 2026. Recent commentary suggests the company offers affordable growth supported by strong fundamentals. The stock is currently trading near its 52-week low, with technical indicators showing a support rejection and volume spike.
Insulet Sets Q3 2026 Earnings Date for Nov 4. Insulet has scheduled its third-quarter 2026 financial results for release on November 4, 2026. Recent commentary suggests the company offers affordable growth supported by strong fundamentals. The stock is currently trading near its 52-week low, with technical indicators showing a support rejection and volume spike.